Q2 2026 saw strong revenue and margin growth, with adjusted EBITDA up 16.3% year-over-year and EPS up 52%. Guidance for 2026 was raised across revenue, EBITDA, and cash flow, supported by high-acuity strategies, disciplined expense management, and robust capital deployment.Based on Tenet Healthcare…
Q2 2026 saw strong revenue and margin growth, with adjusted EBITDA up 16.3% year-over-year and EPS up 52%. Guidance for 2026 was raised across revenue, EBITDA, and cash flow, supported by high-acuity strategies, disciplined expense management, and robust capital deployment.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.